BERKELEY, Calif. and MAINZ, Germany, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that Bill Caragol, Chief Financial Officer, will attend the JonesTrading 2023 Healthcare Summit which will take place October 9-11, 2023 in Miami Beach, Florida.
The Summit will be attended by key opinion leaders, healthcare focused institutional investors, and prominent figures in the next generation of biotechnology innovation. They will address critical trends in drug development and the broader healthcare & biotechnology landscape.
Mr. Caragol will be available for 1-on-1 meetings with investors throughout the event.
For those interested in attending, JonesTrading suggests contacting a company representative - https://www.jonestrading.com/contact-us/
Please follow us to stay up to date:
LinkedIn
X (Previously Twitter)
Facebook
About Mainz Biomed NV
Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert®, ...